Less commonly, mutations in PTEN, WT1, amplification of MYB and sequence mutations in RAS signaling (NRAS, KRAS, and NF1) and tumor suppression (TP53) have been identified in ALL [8, 31]. This evidence concerns the gene WT1 and acute lymphoblastic leukemia.